Drug intelligence / Profile preview

Qiling Granules

Development stage: Preclinical
Administration: Oral

Overview

Qiling Granules, specifically Fufang Qiling granules (FQG), is a traditional Chinese medicine formulation derived from the traditional Qiling Decoction. It is composed of a combination of seven Chinese herbs and is utilized for the treatment of hyperuricemia (HUA). Clinical evidence suggests it effectively reduces uric acid levels and attenuates renal damage. Its pharmacological mechanism involves inhibiting xanthine oxidase (XOD) enzyme activity.

Other names: Fufang Qiling granulesFQG芪苓颗粒

Targets

XO (Xanthine Oxidoreductase)

Beyond the preview

Go deeper on Qiling Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qiling Granules.

Explore the full profile